Intravenous (IV) Pantoprazole in Erosive Esophagitis
تعليق: مشروع دراسة مسجلة (ClinicalTrials.gov Identifier: NCT00133770) في موقع الدراسات الصحية الرسمي الحكومي الأمريكي ومن جامعة محترمة ويلاحظ ان من ضمن خصائص الإستبعاد من الدراسة مشاكل الإبصار وهذا خطير. --احمد شوقي محمدين 18:50، 15 أكتوبر 2016 (ت ع م)
محتويات
Purpose
The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis.
Exclusion Criteria:
................... Patients with history of glaucoma in either eye; history of any intraocular eye surgery within preceding 3 months; history of, or presence of, signs of optic nerve swelling; history of acute change in vision; or vision loss in either eye.
...........
Responsible Party: Dr. Qiang Cai MD/PhD, Professor, Emory University
ClinicalTrials.gov Identifier: NCT00133770 History of Changes
Other Study ID Numbers: 259-2004 3001K-200042
Study First Received: August 22, 2005
Last Updated: July 29, 2013
Health Authority: United States: Food and Drug Administration
